Regulatory FDA moves toward easing restrictions on certain peptides BioPharma DiveThe agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F.RegulatoryRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive The agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. RegulatoryRead full story Post navigation Previous: Lilly’s new obesity pill passes heart safety test in diabetesNext: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026